Pseudotumor cerebri risk factors: Difference between revisions

	Pseudotumor cerebri Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating pseudotumor cerebri from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pseudotumor cerebri risk factors On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pseudotumor cerebri risk factors All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pseudotumor cerebri risk factors
CDC on Pseudotumor cerebri risk factors
Pseudotumor cerebri risk factors in the news
Blogs on Pseudotumor cerebri risk factors
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Pseudotumor cerebri risk factors

VisualWikitext

Revision as of 14:00, 27 July 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Risk Factors

The most potent risk factors in the development of IHH are:

Common risk factors

Age and gender

Most of the IIH cases happen in women in child bearing age (9 uptodate), but it can also happens in children and old adult with male gender. In prepubertal age the gender is not an important risk factor and in old patients the percent of affected males was higher than females.(16-29 uptodate)

Obesity

Positive family history (15 upto)

Medications

growth hormones: Development of IIH in result of GH therapy mostly happens in one year of medication initiation, but it can also develop after several years of treatment. witj stoping the use of GH, symptoms of IIH will improve.(35-38 upto)

Minocycline(39)
Doxycycline(39)
vitamin A(39)

Systemib illness

Addison disease(68)
Hypoparathyroidism(69)
Sever anemia(14)
Sleep apnea(14)
SLE(75)
Behcet’s syndrome(78)
Polycystic ovary syndrome(80)
Coagulation disorders(80)
Uremia(84)

Less common risk factors

drugs such as:

thyroxin(23)
corticosteroid withdrawal(29)
lithium(60)
nalidixic acid(24)
nitrofurantoin(65)

References

Template:WH Template:WS

@@ Line 4: / Line 4: @@
 {{CMG}}; {{AE}}
 ==Overview==
-There are no established risk factors for [disease name].
+==Risk Factors==
+The most potent risk factors in the development of IHH are:
-OR
-The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
-OR
-Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
+=== Common risk factors ===
-OR
+===== Age and gender =====
+Most of the IIH cases happen in women in child bearing age (9 uptodate), but it can also happens in children and old adult with male gender. In prepubertal age the gender is not an important risk factor and in old patients the percent of affected males was higher than females.(16-29 uptodate)
-Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
+===== Obesity =====
-==Risk Factors==
-There are no established risk factors for [disease name].
-OR
+===== Positive family history (15 upto) =====
-The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
+===== Medications =====
+* growth hormones: Development of IIH in result of GH therapy mostly happens in one year of medication initiation, but it can also develop after several years of treatment. witj stoping the use of GH, symptoms of IIH will improve.(35-38 upto)
-OR
+* Minocycline(39)
+* Doxycycline(39)
+* vitamin A(39)
-Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
+===== Systemib illness =====
-===Common Risk Factors===
+* Addison disease(68)
-*Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
+* Hypoparathyroidism(69)
-*Common risk factors in the development of [disease name] include:
+* Sever anemia(14)
-**[Risk factor 1]
+* Sleep apnea(14)
-**[Risk factor 2]
+* SLE(75)
-**[Risk factor 3]
+* Behcet’s syndrome(78)
+* Polycystic ovary syndrome(80)
+* Coagulation disorders(80)
+* Uremia(84)
-===Less Common Risk Factors===
+=== Less common risk factors ===
-*Less common risk factors in the development of [disease name] include:
+drugs such as:
-**[Risk factor 1]
+* thyroxin(23)
-**[Risk factor 2]
+* corticosteroid withdrawal(29)
-**[Risk factor 3]
+* lithium(60)
+* nalidixic acid(24)
+* nitrofurantoin(65)
 ==References==